BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shah SB. COVID-19 and Progesterone: Part 2. Unraveling High Severity, Immunity Patterns, Immunity grading, Progesterone and its potential clinical use. Endocr Metab Sci 2021;:100110. [PMID: 34396354 DOI: 10.1016/j.endmts.2021.100110] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Sharma A, Kaur M, Yadav P, Singh G, Barnwal RP. Expediting the drug discovery for ideal leads against SARS-CoV-2 via molecular docking of repurposed drugs. J Biomol Struct Dyn 2022;:1-17. [PMID: 36165445 DOI: 10.1080/07391102.2022.2127903] [Reference Citation Analysis]
2 Fedotcheva TA, Fedotcheva NI, Shimanovsky NL. Progesterone as an Anti-Inflammatory Drug and Immunomodulator: New Aspects in Hormonal Regulation of the Inflammation. Biomolecules 2022;12:1299. [DOI: 10.3390/biom12091299] [Reference Citation Analysis]
3 Yang D, Li H, Chen Y, Ren W, Dong M, Li C, Jiao Q. Immunomodulatory mechanisms of abatacept: A therapeutic strategy for COVID-19. Front Med 2022;9. [DOI: 10.3389/fmed.2022.951115] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hashimoto Y, Suzuki T, Hashimoto K. Mechanisms of action of fluvoxamine for COVID-19: a historical review. Mol Psychiatry 2022. [PMID: 34997196 DOI: 10.1038/s41380-021-01432-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 22.0] [Reference Citation Analysis]